0001140361-15-031315.txt : 20150812 0001140361-15-031315.hdr.sgml : 20150812 20150812152705 ACCESSION NUMBER: 0001140361-15-031315 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150812 DATE AS OF CHANGE: 20150812 EFFECTIVENESS DATE: 20150812 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Genoa Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001540171 IRS NUMBER: 452463191 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-187115 FILM NUMBER: 151046810 BUSINESS ADDRESS: STREET 1: 12636 HIGH BLUFF DRIVE, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (619) 992-6488 MAIL ADDRESS: STREET 1: 12636 HIGH BLUFF DRIVE, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 D/A 1 primary_doc.xml X0707 D/A LIVE 0001540171 Genoa Pharmaceuticals, Inc. c/o 12670 High Bluff Drive SAN DIEGO CA CALIFORNIA 92130 (619) 992-6488 DELAWARE None None Corporation true 2011 Mark W. Surber, Ph.D. c/o 12670 High Bluff Drive San Diego CA CALIFORNIA 92130 Executive Officer Director Richard G. Vincent c/o 12670 High Bluff Drive San Diego CA CALIFORNIA 92130 Executive Officer Michael J. Kamdar c/o 12670 High Bluff Drive San Diego CA CALIFORNIA 92130 Director Daniel D. Burgess c/o 12670 High Bluff Drive San Diego CA CALIFORNIA 92130 Director Pharmaceuticals Decline to Disclose 06b true 0001540171-12-000003 2011-10-23 true true true true false 1 2179480 2179480 0 false 41 0 0 0 false Genoa Pharmaceuticals, Inc. /s/ Mark W. Surber, Ph.D. Mark W. Surber, Ph.D. President and Chief Executive Officer 2015-08-11